Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro does not have a recognised side effect of producing a body odour or unusual smell in clinical trials or its official prescribing information. The smell questions circulating online mostly relate to changes in urine or breath, which have plausible explanations — and a few that don't hold up. These are prescription-only medicines reviewed by a clinician before supply, and any new or persistent symptom you notice on treatment is worth raising with your prescriber. Here's what the evidence actually says.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common claim online is that tirzepatide causes a distinctive body smell, sometimes described as sweet or chemical. It's understandable that people make this connection, you start a new medicine, something changes, you look for a cause. But the NHS tirzepatide medicines page and the full UK prescribing information for Mounjaro do not list body odour as a known adverse effect. It didn't appear in the SURMOUNT clinical programme involving thousands of adults, either.
What people are often noticing is something real, just not directly caused by the molecule itself. The more useful question is: what has changed because of how Mounjaro works, and could that account for the smell?
Mounjaro is a dual GIP and GLP-1 receptor agonist. It slows gastric emptying and reduces appetite significantly. Both of those effects change what you eat, how much you drink and how your body processes fuel, and all of those things can influence how you smell. The medicine is the context, not the cause.
Several patients notice their urine smells stronger or different, particularly in the first weeks of treatment. The likeliest explanation is straightforward: Mounjaro suppresses appetite, and for many people that also means drinking less. Concentrated urine smells more pronounced, it's the same effect you'd notice after a night's sleep or a hot day without enough water. It has nothing to do with tirzepatide's pharmacology.
There's a separate concern worth knowing. Gastrointestinal side effects (nausea, vomiting, loose stools) are the most common effects associated with tirzepatide, particularly after starting or after a dose step. Repeated vomiting or diarrhoea can cause dehydration faster than people expect, and dehydration makes concentrated urine worse and can strain the kidneys over time. The fuller picture on Mounjaro and urine smell is covered separately, but the practical takeaway is the same: if your urine is dark or smells noticeably stronger, drink more water and tell your prescriber if the GI effects are severe.
You can read about urine odour and tirzepatide in more detail, including what signs would need medical attention rather than just a hydration top-up.
A smaller number of people report a change in breath, sometimes described as slightly sweet or fruity. This is much more likely to be a diet-related effect than a direct medicine effect. When calorie intake falls sharply (Mounjaro reduces appetite considerably in many people), the body draws on fat stores for energy. That process produces ketone bodies as a byproduct, and ketones are exhaled, which is exactly why low-carbohydrate and very-low-calorie diets are associated with noticeable breath changes.
This isn't dangerous in the context of weight management in people without type 1 diabetes, it simply reflects the metabolic shift happening. Staying well hydrated, maintaining adequate protein, and not letting calorie intake fall lower than it needs to all help. For personalised guidance on eating patterns alongside tirzepatide treatment, your prescriber or a dietitian is the right port of call, not forum advice.
If you're curious about how other patients' experiences compare, the question of whether Mounjaro causes a bad smell gets into some of the broader reports in more detail. Pricing context for treatment is on the Mounjaro prices page if that's on your mind.
Most smell changes on Mounjaro resolve once hydration improves and the body adjusts to a different intake level. But a few situations warrant a conversation with a clinician rather than waiting it out.
A very strong, fishy or ammonia-like urine smell that doesn't improve with better hydration could suggest a urinary tract infection or another issue unrelated to the medicine. Similarly, a fruity breath smell in someone with type 2 diabetes should prompt a blood glucose check, since diabetic ketoacidosis (DKA) (while uncommon and more typical in type 1 diabetes) does produce that odour. The MHRA's Yellow Card scheme exists for patients to report any new or unexpected symptom they think might be connected to a medicine, and it's genuinely useful data.
More broadly, any symptom that worries you on treatment should go to your prescriber. At nume, a real clinician (not a triage algorithm) reads your concern the same day you raise it. If you're thinking about starting treatment or want aftercare support you can actually reach, speak to our prescribers to get started, and you can also explore the Mounjaro weight loss app if you'd like extra tools to track your progress alongside clinical support.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.